Skip to Main Content

Author Details

Motomi Mori
St Jude Children's Research Hospital.
1988
152
54
PMIDPaper TitleJournal TitlePublished Year
36824803An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequences.Res Sq2023
37365517An open protocol for modeling T Cell Clonotype repertoires using TCRβ CDR3 sequences.BMC Genomics2023
37194488Feasibility of indocyanine green-guided localization of pulmonary nodules in children with solid tumors.Pediatr Blood Cancer2023
35266368GMEPS: a fast and efficient likelihood approach for genome-wide mediation analysis under extreme phenotype sequencing.Stat Appl Genet Mol Biol2022
35840948covidscreen: a web app and R Package for assessing asymptomatic COVID-19 testing strategies.BMC Public Health2022
35471132Managing Pandora's Box: Familial Expectations around the Return of (Future) Germline Results.AJOB Empir Bioeth2022
35868306Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.Cancer Cell2022
36239933Young-Onset Breast Cancer Outcomes by Time Since Recent Childbirth in Utah.JAMA Netw Open2022
33727309Leukocyte Heterogeneity in Pancreatic Ductal Adenocarcinoma: Phenotypic and Spatial Features Associated with Clinical Outcome.Cancer Discov2021
33570491Cytoneme delivery of Sonic Hedgehog from ligand-producing cells requires Myosin 10 and a Dispatched-BOC/CDON co-receptor complex.Elife2021
31155953Sulforaphane Bioavailability and Chemopreventive Activity in Men Presenting for Biopsy of the Prostate Gland: A Randomized Controlled Trial.Nutr Cancer2020
32094466Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia.Leukemia2020
32513686Reversible suppression of T cell function in the bone marrow microenvironment of acute myeloid leukemia.Proc Natl Acad Sci U S A2020
32482525A Randomized Parallel Controlled Phase II Trial of Recombinant Human Endostatin Added to Neoadjuvant Chemotherapy for Stage III Breast Cancer.Clin Breast Cancer2020
30646210Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk.JAMA Netw Open2019
31816063Patients with FLT3-mutant AML needed to enroll on FLT3-targeted therapeutic clinical trials.Blood Adv2019
31839883A way forward for cancer prevention therapy: personalized risk assessment.Oncotarget2019
31177537Phase 1-2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma.Br J Haematol2019
30425048CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells.Blood2019
28774957Perceptions of control and unrealistic optimism in early-phase cancer trials.J Med Ethics2018
30082821Dual inhibition of JAK1/2 kinases and BCL2: a promising therapeutic strategy for acute myeloid leukemia.Leukemia2018
30239392MiR-486-5p Downregulation Marks an Early Event in Colorectal Carcinogenesis.Dis Colon Rectum2018
30333627Functional genomic landscape of acute myeloid leukaemia.Nature2018
30381467IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin.J Exp Med2018
29782360A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer.Am J Clin Oncol2018
29743719Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes.Leukemia2018
27429350Randomized, double-blind, placebo-controlled study of methylphenidate for the treatment of depression in SSRI-treated cancer patients receiving palliative care.Psychooncology2017
28380359Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis.Cell Rep2017
29473059Assessing Community Cancer care after insurance ExpanSionS (ACCESS) study protocol.Contemp Clin Trials Commun2017
28784769Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies.Proc Natl Acad Sci U S A2017
28728498Variations in Unrealistic Optimism Between Acceptors and Decliners of Early Phase Cancer Trials.J Empir Res Hum Res Ethics2017
27974414The Rodent Liver Undergoes Weaning-Induced Involution and Supports Breast Cancer Metastasis.Cancer Discov2017
27680514Mutational profiling of a MonoMAC syndrome family with GATA2 deficiency.Leukemia2017
22461073A new statistical decision rule for single-arm phase II oncology trials.Stat Methods Med Res2016
30146857The Impact of Unrealistic Optimism on Informed Consent in Early-Phase Oncology Trials.IRB2016
27646578Effects of Ï¿-3 Fatty Acids and Catechins on Fatty Acid Synthase in the Prostate: A Randomized Controlled Trial.Nutr Cancer2016
27658891MicroRNA Signatures of Colonic Polyps on Screening and Histology.Cancer Prev Res (Phila)2016
27235757Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women.Exp Hematol2016
26882017Dispositional optimism and therapeutic expectations in early-phase oncology trials.Cancer2016
27060790Durability of Vaccine-Induced Immunity Against Tetanus and Diphtheria Toxins: A Cross-sectional Analysis.Clin Infect Dis2016
26953989Treatment and Survival of Small-bowel Adenocarcinoma in the United States: A Comparison With Colon Cancer.Dis Colon Rectum2016
25431127A phase II study of sulforaphane-rich broccoli sprout extracts in men with recurrent prostate cancer.Invest New Drugs2015
26511489Sulforaphane Bioavailability and Chemopreventive Activity in Women Scheduled for Breast Biopsy.Cancer Prev Res (Phila)2015
24142376Differences in knowledge, attitudes, beliefs, and perceived risks regarding colorectal cancer screening among Chinese, Korean, and Vietnamese sub-groups.J Community Health2014
25201936The association of type and number of chronic diseases with breast, cervical, and colorectal cancer screening.J Am Board Fam Med2014
24791633Differential expression of microRNA-320a, -145, and -192 along the continuum of normal mucosa to high-grade dysplastic adenomas of the colorectum.Am J Surg2014
24595714Improving colorectal cancer screening in Asian Americans: Results of a randomized intervention study.Cancer2014
24685386Assisted movement with proprioceptive stimulation reduces impairment and restores function in incomplete spinal cord injury.Arch Phys Med Rehabil2014
23371962Documentation and management of CKD in rural primary care.Clin J Am Soc Nephrol2013
24132922Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates.Clin Cancer Res2013
  • 1 - 50 of 152

Recommended Authors

University of California Los Angeles
Career Start Year 2013
Number of shared co-authors 0
Center for Innovative Design and Analysis, University of Colorado, Aurora CO.
Career Start Year 2008
Number of shared co-authors 6
University of California
Career Start Year 2003
Number of shared co-authors 1
University of Virginia
Career Start Year 2002
Number of shared co-authors 0
McGill University
Career Start Year 2001
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus
Career Start Year 2001
Number of shared co-authors 4
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 1
University of California san francisco
Career Start Year 2000
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 1
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 0
Stanford University
Career Start Year 1997
Number of shared co-authors 1
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 6
The University of Kansas Medical Center
Career Start Year 1996
Number of shared co-authors 1
Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 1994
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 1992
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 4
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 1
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1986
Number of shared co-authors 2
Harvard Medical School
Career Start Year 1985
Number of shared co-authors 0
and Clinical Center, Central Arkansas Veterans Healthcare System
Career Start Year 1984
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 3
Rollins School of Public Health, Emory University School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 4
University of California davis
Career Start Year 1983
Number of shared co-authors 2
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 0
Mass General Hospital
Career Start Year 1977
Number of shared co-authors 1
NYU Grossman School of Medicine
Career Start Year 1974
Number of shared co-authors 0
Health Informatics Institute, University of South Florida
Career Start Year 1971
Number of shared co-authors 0

Collaborators

OHSU Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 19
Oregon Health & Science University
Co-authored papers 13
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 11
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 9
Oregon Health & Science University School of Medicine
Co-authored papers 8
OCHIN Inc.
Co-authored papers 7
Oregon Health & Science University
Co-authored papers 7
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 6
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 6
Co-authored papers 6
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 6
Oregon Health & Science University, University of California Berkeley
Co-authored papers 6
University of Utah Huntsman Cancer Institute
Co-authored papers 6
Oregon Health and Science University
Co-authored papers 5
Co-authored papers 5
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 5
Knight Cancer Institute, Oregon Health and Science University
Co-authored papers 5
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 5
National Cancer Institute
Co-authored papers 4
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 4
Oregon Health & Science University
Co-authored papers 4
Center for Law, Columbia University Irving Medical Center
Co-authored papers 4
The Ohio State University
Co-authored papers 4
Co-authored papers 4
University of Miami, Sylvester Comprehensive Cancer Center
Co-authored papers 3
Icahn School of Medicine
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 3
Astex Pharmaceuticals
Co-authored papers 3
Oregon Health & Science University
Co-authored papers 3